{
    "id": "58508562",
    "text": "Levonorgestrel cyclobutylcarboxylate (or levonorgestrel 17\u03b2-cyclobutylcarboxylate; developmental code name HRP-001) is a progestin and a progestogen ester which was studied for potential use as an injectable hormonal contraceptive but was never marketed.Benagiano, G., & Merialdi, M. (2011). Carl Djerassi and the World Health Organisation special programme of research in human reproduction. Journal f\u00fcr Reproduktionsmedizin und Endokrinologie-Journal of Reproductive Medicine and Endocrinology, 8(1), 10-13. http://www.kup.at/kup/pdf/10163.pdf It was developed by the World Health Organization's Special Programme on Human Reproduction in the 1980s. Analogues of levonorgestrel cyclobutylcarboxylate include levonorgestrel butanoate (HRP-002) and levonorgestrel cyclopropylcarboxylate (HRP-003). ==See also== * List of progestogen esters \u00a7 Esters of 19-nortestosterone derivatives * Progestogen-only injectable contraceptive ==References== Category:Abandoned drugs Category:Alkyne derivatives Category:Androgens and anabolic steroids Category:Carboxylic acids Category:Estranes Category:Enones Category:Prodrugs Category:Progestogens Category:Progestogen esters Category:World Health Organization ",
    "title": "Levonorgestrel cyclobutylcarboxylate"
}